Literature DB >> 11973365

Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.

Thomas J Nuckton1, James A Alonso, Richard H Kallet, Brian M Daniel, Jean-François Pittet, Mark D Eisner, Michael A Matthay.   

Abstract

BACKGROUND: No single pulmonary-specific variable, including the severity of hypoxemia, has been found to predict the risk of death independently when measured early in the course of the acute respiratory distress syndrome. Because an increase in the pulmonary dead-space fraction has been described in observational studies of the syndrome, we systematically measured the dead-space fraction early in the course of the illness and evaluated its potential association with the risk of death.
METHODS: The dead-space fraction was prospectively measured in 179 intubated patients, a mean (+/-SD) of 10.9+/-7.4 hours after the acute respiratory distress syndrome had developed. Additional clinical and physiological variables were analyzed with the use of multiple logistic regression. The study outcome was mortality before hospital discharge.
RESULTS: The mean dead-space fraction was markedly elevated (0.58+/-0.09) early in the course of the acute respiratory distress syndrome and was higher among patients who died than among those who survived (0.63+/-0.10 vs. 0.54+/-0.09, P<0.001). The dead-space fraction was an independent risk factor for death: for every 0.05 increase, the odds of death increased by 45 percent (odds ratio, 1.45; 95 percent confidence interval, 1.15 to 1.83; P=0.002). The only other independent predictors of an increased risk of death were the Simplified Acute Physiology Score II, an indicator of the severity of illness (odds ratio, 1.06; 95 percent confidence interval, 1.03 to 1.08; P<0.001) and quasistatic respiratory compliance (odds ratio, 1.06; 95 percent confidence interval, 1.01 to 1.10; P=0.01).
CONCLUSIONS: Increased dead-space fraction is a feature of the early phase of the acute respiratory distress syndrome. Elevated values are associated with an increased risk of death.

Entities:  

Mesh:

Year:  2002        PMID: 11973365     DOI: 10.1056/NEJMoa012835

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  206 in total

Review 1.  Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

Authors:  Michael A Matthay; B Taylor Thompson; Elizabeth J Read; David H McKenna; Kathleen D Liu; Carolyn S Calfee; Jae Woo Lee
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Dead space.

Authors:  U Lucangelo; L Blanch
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

3.  [High-flow oxygen therapy in hypoxic respiratory failure : Possible alternative to noninvasive ventilation].

Authors:  B Schönhofer
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-18       Impact factor: 0.840

Review 4.  Using the features of the time and volumetric capnogram for classification and prediction.

Authors:  Michael B Jaffe
Journal:  J Clin Monit Comput       Date:  2016-01-18       Impact factor: 2.502

5.  Acute cor pulmonale and the acute respiratory distress syndrome.

Authors:  Claude Guérin; Michael A Matthay
Journal:  Intensive Care Med       Date:  2016-01-13       Impact factor: 17.440

6.  [Comments on: High-flow oxygen administration through a nasal cannula in acute hypoxemic respiratory failure].

Authors:  G Schälte; M Coburn
Journal:  Anaesthesist       Date:  2015-08       Impact factor: 1.041

7.  Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure: impact and clinical fallout through the following 20 years.

Authors:  Luciano Gattinoni; Antonio Pesenti; Eleonora Carlesso
Journal:  Intensive Care Med       Date:  2013-09-12       Impact factor: 17.440

Review 8.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

9.  Ventilatory strategies in patients with sepsis and respiratory failure.

Authors:  Dean R Hess; B Taylor Thompson
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

10.  Biomarkers in acute lung injury: are we making progress?

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.